Androgen dynamics and serum PSA in patients treated with abiraterone acetate

Por Ryan, C J, Peng, W, Kheoh, T, Welkowsky, E, Haqq, C M, Chandler, D W, Scher, H I, Molina, A
Publicado em 2014

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer

Por Goodman, O B, Flaig, T W, Molina, A, Mulders, P F A, Fizazi, K, Suttmann, H, Li, J, Kheoh, T, de Bono, J S, Scher, H I
Publicado em 2014

Serum Androgens As Prognostic Biomarkers in Castration-Resistant Prostate Cancer: Results From an Analysis of a Randomized Phase III Trial

Por Ryan, Charles J., Molina, Arturo, Li, Jinhui, Kheoh, Thian, Small, Eric J., Haqq, Christopher M., Grant, Russell P., de Bono, Johann S., Scher, Howard I.
Publicado no J Clin Oncol (2013)

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Por Tolcher, A. W., Chi, K. N., Shore, N. D., Pili, R., Molina, A., Acharya, M., Kheoh, T., Jiao, J. J., Gonzalez, M., Trinh, A., Pankras, C., Tran, N.
Publicado em 2012

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer(†)

Por O'Shaughnessy, J., Campone, M., Brain, E., Neven, P., Hayes, D., Bondarenko, I., Griffin, T. W., Martin, J., De Porre, P., Kheoh, T., Yu, M. K., Peng, W., Johnston, S.
Publicado no Ann Oncol (2016)

Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

Por Smith, Matthew R., Rathkopf, Dana E., Mulders, Peter. F.A., Carles, Joan, Van Poppel, Hendrik, Li, Jinhui, Kheoh, Thian, Griffin, Thomas W., Molina, Arturo, Ryan, Charles J.
Publicado no J Urol (2015)

Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconaz...

Por Ryan, Charles J., Smith, Matthew R., Fong, Lawrence, Rosenberg, Jonathan E., Kantoff, Philip, Raynaud, Florence, Martins, Vanessa, Lee, Gloria, Kheoh, Thian, Kim, Jennifer, Molina, Arturo, Small, Eric J.
Publicado em 2010

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

Por Ryan, Charles J., Kheoh, Thian, Li, Jinhui, Molina, Arturo, De Porre, Peter, Carles, Joan, Efstathiou, Eleni, Kantoff, Philip W., Mulders, Peter F.A., Saad, Fred, Chi, Kim N.
Publicado no Clin Genitourin Cancer (2017)

Phase II Study of Abiraterone Acetate Plus Prednisone in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Demonstrating Radiographic Flare Discordant With Serolog...

Por Ryan, Charles J., Shah, Shreya, Efstathiou, Eleni, Smith, Matthew R., Taplin, Mary-Ellen, Bubley, Glenn J., Logothetis, Christopher J., Kheoh, Thian, Kilian, Christine, Haqq, Chris, Molina, Arturo, Small, Eric J.
Publicado em 2011

Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone...

Por Fizazi, K., Flaig, T. W., Stöckle, M., Scher, H. I., de Bono, J. S., Rathkopf, D. E., Ryan, C. J., Kheoh, T., Li, J., Todd, M. B., Griffin, T. W., Molina, A., Ohlmann, C. H.
Publicado no Ann Oncol (2016)

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Fi...

Por Heller, Glenn, McCormack, Robert, Kheoh, Thian, Molina, Arturo, Smith, Matthew R., Dreicer, Robert, Saad, Fred, de Wit, Ronald, Aftab, Dana T., Hirmand, Mohammad, Limon, Ana, Fizazi, Karim, Fleisher, Martin, de Bono, Johann S., Scher, Howard I.
Publicado no J Clin Oncol (2018)

Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer

Por Scher, Howard I., Heller, Glenn, Molina, Arturo, Attard, Gerhardt, Danila, Daniel C., Jia, Xiaoyu, Peng, Weimin, Sandhu, Shahneen K., Olmos, David, Riisnaes, Ruth, McCormack, Robert, Burzykowski, Tomasz, Kheoh, Thian, Fleisher, Martin, Buyse, Marc, de Bono, Johann S.
Publicado no J Clin Oncol (2015)

ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA

Por Accomando, William, Cloughesy, Timothy, Kalkanis, Steven, Mikkelsen, Tom, Landolfi, Joseph, Carter, Bob, Chen, Clark, Vogelbaum, Michael, Elder, James, Piccioni, David, Walbert, Tobias, Hogan, Daniel, Diago, Oscar, Gammon, Dawn, Haghighi, Ali, Kheoh, Thian, Gruber, Harry, Jolly, Douglas, Ostertag, Derek
Publicado no Neuro Oncol (2018)

Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302

Por de Bono, Johann S., Smith, Matthew R., Saad, Fred, Rathkopf, Dana E., Mulders, Peter F.A., Small, Eric J., Shore, Neal D., Fizazi, Karim, De Porre, Peter, Kheoh, Thian, Li, Jinhui, Todd, Mary B., Ryan, Charles J., Flaig, Thomas W.
Publicado no Eur Urol (2016)

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with...

Por Efstathiou, Eleni, Davis, John W., Pisters, Louis, Li, Weimin, Wen, Sijin, McMullin, Ryan P., Gormley, Michael, Ricci, Deborah, Titus, Mark, Hoang, Anh, Zurita, Amado J., Tran, NamPhuong, Peng, Weimin, Kheoh, Thian, Molina, Arturo, Troncoso, Patricia, Logothetis, Christopher J.
Publicado no Eur Urol (2019)

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel

Por Chi, K. N., Kheoh, T., Ryan, C. J., Molina, A., Bellmunt, J., Vogelzang, N. J., Rathkopf, D. E., Fizazi, K., Kantoff, P. W., Li, J., Azad, A. A., Eigl, B. J., Heng, D. Y. C., Joshua, A. M., de Bono, J. S., Scher, H. I.
Publicado no Ann Oncol (2016)

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer

Por Lorente, David, Olmos, David, Mateo, Joaquin, Bianchini, Diletta, Seed, George, Fleisher, Martin, Danila, Daniel C., Flohr, Penny, Crespo, Mateus, Figueiredo, Ines, Miranda, Susana, Baeten, Kurt, Molina, Arturo, Kheoh, Thian, McCormack, Robert, Terstappen, Leon W.M.M., Scher, Howard I., de Bono, Johann S.
Publicado no Eur Urol (2016)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

Por Rydzewska, Larysa H.M., Burdett, Sarah, Vale, Claire L., Clarke, Noel W., Fizazi, Karim, Kheoh, Thian, Mason, Malcolm D., Miladinovic, Branko, James, Nicholas D., Parmar, Mahesh K.B., Spears, Melissa R., Sweeney, Christopher J., Sydes, Matthew R., Tran, NamPhuong, Tierney, Jayne F.
Publicado no Eur J Cancer (2017)

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

Por Danila, Daniel C., Morris, Michael J., de Bono, Johann S., Ryan, Charles J., Denmeade, Samuel R., Smith, Matthew R., Taplin, Mary-Ellen, Bubley, Glenn J., Kheoh, Thian, Haqq, Christopher, Molina, Arturo, Anand, Aseem, Koscuiszka, Michael, Larson, Steve M., Schwartz, Lawrence H., Fleisher, Martin, Scher, Howard I.
Publicado em 2010

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

Por Attard, Gerhardt, Reid, Alison H.M., A’Hern, Roger, Parker, Christopher, Oommen, Nikhil Babu, Folkerd, Elizabeth, Messiou, Christina, Molife, L. Rhoda, Maier, Gal, Thompson, Emilda, Olmos, David, Sinha, Rajesh, Lee, Gloria, Dowsett, Mitch, Kaye, Stan B., Dearnaley, David, Kheoh, Thian, Molina, Arturo, de Bono, Johann S.
Publicado em 2009